## BEN: Franklin Resources, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($23.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Franklin Resources Falls Below Substantial Holder Threshold in Ausgold**
- Source: TipRanks | 20251228T221400 | Neutral | Relevance: 87%
- Franklin Resources and its affiliates have ceased to be a substantial holder in Ausgold Limited, with their voting power dropping from 5.43% to 4.94%. This occurred despite an increase in their absolute shareholding, as Ausgold's total shares on issue expanded, leading to a dilution of Franklin Resources' relative influence. The market is expected to closely watch this shift in the companyâ€™s shareholder landscape.

**2. Voya Investment Management LLC Sells 44,253 Shares of Commercial Metals Company $CMC**
- Source: MarketBeat | 20251227T130946 | Neutral | Relevance: 67%
- Voya Investment Management LLC reduced its stake in Commercial Metals Company (NYSE:CMC) by 39.6% during the third quarter, selling 44,253 shares and retaining 67,446 shares valued at $3.86 million. Despite Voya's reduction, other institutional investors like Norges Bank and Millennium Management significantly increased or initiated positions, with institutional and hedge funds now owning 86.9% of the stock. Analysts have generally been positive, with several upgrades and an average target price of $67.50, indicating a "Moderate Buy" consensus.

**3. Annex Advisory Services LLC Has $8.55 Million Stake in Thermo Fisher Scientific Inc. $TMO**
- Source: MarketBeat | 20251229T081651 | Neutral | Relevance: 65%
- Annex Advisory Services LLC significantly increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 93.7% in Q3, now holding 17,620 shares valued at approximately $8.55 million. This comes as company insiders were net sellers, offloading 149,271 shares worth about $86.5 million over the past 90 days. Despite insider sales, Thermo Fisher Scientific reported strong quarterly earnings, beating estimates, and authorized a $5.0 billion share buyback program.

**4. PineStone Asset Management Inc. Sells 10,810 Shares of Hilton Worldwide Holdings Inc. $HLT**
- Source: MarketBeat | 20251228T125618 | Neutral | Relevance: 65%
- PineStone Asset Management Inc. reduced its stake in Hilton Worldwide Holdings Inc. (NYSE:HLT) by 1.3% in the third quarter, selling 10,810 shares. Despite this sale, Hilton remains PineStone's 24th largest holding, valued at $216.3 million, and institutional investors collectively own 95.9% of the stock. Analysts currently rate Hilton a "Moderate Buy" with a consensus target price of $285.31, while the company has announced a quarterly dividend of $0.15 per share.

**5. Merck & Co., Inc. $MRK Shares Sold by Ethic Inc.**
- Source: MarketBeat | 20251229T095234 | Somewhat-Bullish | Relevance: 64%
- Ethic Inc. recently reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 3.2%, selling 9,582 shares, though the company remains a significant holding. Concurrently, several other large institutional investors, including DLD Asset Management and Norges Bank, have increased their positions in Merck, leading to institutional ownership of approximately 76.07% of the stock. Analysts largely maintain a "Hold" rating with an average target price of $110.13, and Merck has boosted its quarterly dividend to $0.85 per share, offering a 3.2% yield.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Barclays | $22 | $20 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($13.53M) |
| Sells | 6 ($40.97M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 7.1% (-1.5%)
- Power Corp of Canada: 6.1% (0.0%)
- Blackrock Inc.: 5.4% (+0.7%)
- State Street Corpora: 4.0% (-5.8%)
- Dimensional Fund Adv: 1.9% (+5.8%)

### Key Risks

1. Heavy insider selling: $41M sold (6 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.38 indicates undervaluation relative to growth. Forward P/E 8.8x attractive for 12% earnings growth. Balance sheet: strong liquidity (2.7x). Analyst sentiment positive (1 raises, avg +10%). Insider selling cluster ($41.0M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.7B |
| Beta | 1.49 |
| 52W Range | $16.25 - $26.08 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.38 |
| Forward P/E | 8.8 |
| Current P/E | 9.8 |
| YoY Growth | 11.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.0% to 0.7% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.74% (CS: 82) | Neutral |
| RSI_14 | 65.9 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.035x | Above |
| vs SMA50 | 1.065x | Above |
| vs SMA200 | 1.080x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $24.39
- **Stop Loss:** $23.47 (3.8% risk)
- **Target:** $25.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 937
- **Position Value:** $22,853.43
- **Portfolio %:** 22.85%
- **Risk Dollars:** $862.50
- **Risk Per Trade:** 0.86%
- **Modifiers:** L1 115% | L2 75% | Combined 0.86x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-06 (Est: $0.59)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.59 | $0.67 | +14.0% |
| 2025Q2 | $0.50 | $0.49 | -2.3% |
| 2025Q1 | $0.47 | $0.47 | -0.6% |
| 2024Q4 | $0.53 | $0.59 | +11.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*